ARTICLESAlteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion
References (17)
- et al.
Acute pulmonary embolism treated with tissue plasminogen activator
Lancet
(1986) - et al.
Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator
JACC
(1987) - et al.
Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism
Lancet
(1988) - et al.
Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomised controlled multicenter trial
JACC
(1992) - et al.
Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial
JACC
(1992) - et al.
PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism: Plasminogen Activator Italian Multicenter Study 2
JACC
(1992) Pulmonary embolism thrombolysis: a clarion call for international collaboration
JACC
(1992)- et al.
Pulmonary perfusion after rt-PA therapy for acute embolism: early improvement assessed with segmental perfusion scanning
Radiology
(1988)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1993 Published by Elsevier Ltd.